Dr. Bruce Werber is a seasoned Entrepreneur – Researcher – Physician with a successful track record for guiding teams in the biotech industry.

He has over 15+ years of business development, design expertise, clinical experience, coaching, and team building credentials and has established a reputation for cultivating positive metrics that promote operational growth. His superb interpersonal skills have contributed to cultivating positive rapport and opening new accounts for businesses.

Dr. Werber is a strategic thinker who can develop innovative methodologies to increase new business opportunities.
He has more than 35 years of surgical experience comprising over 30k lower extremity limb preservation and reconstruction procedures performed, and 25 years in limb reconstruction for children’s surgical missions with Operation FootPrint in Mexico, Honduras and India.

Currently, Dr. Werber is a consultant to several regenerative laboratories. During the years 2015 to the present in addition to being a lower extremity reconstructive surgeon he is consulting in orthopedics and having worked with several tissue banks in time period as CSO, CMO and president. He has created various processes to create functional safe perinatal regenerative allografts for the regenerative medicine arena.

From 1981 to 2014, Dr. Werber practiced as a Board-Certified reconstructive foot and ankle surgeon in Rhode Island and then in Arizona, the CEO of several medical practices 1981 until 2017. In 2012, Dr. Werber founded and, from 2012 to 2015, served as the President of Amnio Technology LLC, creating the company as well as developing the processing and clinical science related to utilizing placental tissue in orthopedic medicine.

Then working with BPSR (Organicell) to develop the science, placental and exosome allografts, then moving on to Anu Life Sciences which was then acquired by BioStem Life Sciences. Lastly moving to Thrivell to develop further improvements in processing and the science of how and why these tissues work to regenerate injured tissues/organs.

Prior to founding Amnio Technology, Dr. Werber wrote and published two peer reviewed papers relating to using placental tissue in the treatment of diabetic wounds, plantar fasciosis and Achilles’ tendinosis. Dr. Werber has spoken and lectured on this topic extensively around the United States and internationally presenting on a wide variety of lower extremity issues and regenerative therapeutics.

Dr. Werber has completed surgical fellowships in 2003 Athens Institute for Orthopedics in Athens Greece, 2002/04 at the Ilizarov Institute in Kurgan Russia, and in 1989 Hadassah Hospital Jerusalem Israel. Developing expertise in limb preservation techniques most notably reconstruction of the Charcot Foot with external fixation. Teaching positions as Professor at Midwestern University in Phoenix, AZ, and past faculty of Root Biomechanical Foundation and clinical faculty at Temple University. Surgical resident instructor for over 30 years in both Rhode Island and Arizona.

Dr. Werber has submitted eight patent applications in the area of placental tissue, 3 of which are still pending and 4 that have been granted. Plus 2 additional patents in orthopedic implant designs. Dr. Werber served as the President of the American College of Foot and Ankle surgeons from 2003 to 2004. He has been a leader in the field of foot and ankle surgery, introducing new successful technologies to improve patient outcomes.

Dr. Werber earned his DPM (Doctor of Podiatric Medicine) in 1980 from the California College of Podiatric Medicine in San Francisco, CA, and a B.S. in Biology-Physics in 1976 from Syracuse University in Syracuse, NY